Ace Blend, a direct-to-consumer (D2C) nutrition and dietary supplements brand, has raised $9.9 million (approximately Rs 95 crore) in a Series A2 funding round led by 3one4 Capital, with participation from existing investor Fireside Ventures.
The company plans to deploy the fresh capital towards clinical trials, research and development (R&D), supply chain improvements, and the development of new nutrition formats.
Shivam Hingorani, Founder and CEO, Ace Blend said, “The first is clinical trials, which are going to be run by credible CROs (contract research organisations) and are intended to be published in peer-reviewed international journals. The second is cementing our moat as a business, which is our supply chain proficiency. The third is a robust testing mechanism that allows nutritional accuracy, pesticides, and heavy metals to be tested batch on batch without any human intervention.”
The company also intends to conduct shelf-stability studies when products are introduced and again after six months. According to Hingorani, these studies will help establish long-term safety data for its product portfolio.
Emphasising the importance of scientific validation in the nutritional supplements industry, Hingorani said, “Trust is not enough”.
Founded in 2018 by Hingorani, Ace Blend was joined by Saif Mehkri as co-founder in 2022. The company offers dietary supplements across categories such as heart health, brain health, sleep, recovery, gut health, strength and immunity. Its portfolio comprises approximately 14 stock-keeping units (SKUs), including plant-based protein powders, superfood mixes and functional health supplements.
Ace Blend sells its products through its website and online commerce platforms, including Amazon, Flipkart, Zepto and Blinkit. Hingorani said the company's website contributes around 50 percent of its revenue, while the remaining share comes from marketplaces and other e-commerce channels.
According to Hingorani, the startup recorded 300 percent growth in FY26 and has a repeat purchase rate of nearly 48 percent. It is targeting annual recurring revenue (ARR) of Rs 250-300 crore over the next 12-18 months, with profitability also within its plans.
The company is looking to strengthen its supply chain by procuring raw materials from multiple countries. Its vertically integrated operating model covers ingredient sourcing, formulation, and manufacturing. Ace Blend is also working towards implementing automated testing to assess nutritional accuracy, pesticide residues, and heavy metals in every batch.
The startup is developing several new products, including a formulation designed with a gut-health specialist to address leaky gut, a blend of natural nutrients intended to reduce inflammation, an eye-health supplement and a fibre-based product for gut health, Hingorani said.
The funding comes amid growing consumer interest in preventive healthcare and dietary supplements in India. Increasing awareness of nutrition and the role of supplements in managing chronic conditions has also attracted investor attention to the sector. Earlier this month, D2C supplement brand The Stack raised Rs 21.5 crore to expand its product portfolio and invest in research and development.